Literature DB >> 15875256

Cement from magnesium substituted hydroxyapatite.

K J Lilley1, U Gbureck, J C Knowles, D F Farrar, J E Barralet.   

Abstract

Brushite cement may be used as a bone graft material and is more soluble than apatite in physiological conditions. Consequently it is considerably more resorbable in vivo than apatite forming cements. Brushite cement formation has previously been reported by our group following the mixture of nanocrystalline hydroxyapatite and phosphoric acid. In this study, brushite cement was formed from the reaction of nanocrystalline magnesium-substituted hydroxyapatite with phosphoric acid in an attempt to produce a magnesium substituted brushite cement. The presence of magnesium was shown to have a strong effect on cement composition and strength. Additionally the presence of magnesium in brushite cement was found to reduce the extent of brushite hydrolysis resulting in the formation of HA. By incorporating magnesium ions in the apatite reactant structure the concentration of magnesium ions in the liquid phase of the cement was controlled by the dissolution rate of the apatite. This approach may be used to supply other ions to cement systems during setting as a means to manipulate the clinical performance and characteristics of brushite cements.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15875256     DOI: 10.1007/s10856-005-6986-3

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  16 in total

1.  Nanocrystals of magnesium and fluoride substituted hydroxyapatite.

Authors:  E Bertoni; A Bigi; G Cojazzi; M Gandolfi; S Panzavolta; N Roveri
Journal:  J Inorg Biochem       Date:  1998-10       Impact factor: 4.155

2.  Resorption of, and bone formation from, new beta-tricalcium phosphate-monocalcium phosphate cements: an in vivo study.

Authors:  K Ohura; M Bohner; P Hardouin; J Lemaître; G Pasquier; B Flautre
Journal:  J Biomed Mater Res       Date:  1996-02

3.  Crystallographic properties of heterogeneous Mg-containing fluoridated apatites synthesized with a two-step supply system.

Authors:  M Okazaki
Journal:  Biomaterials       Date:  1995-06       Impact factor: 12.479

4.  Indications for hydroxyapatite cement reconstruction in lateral skull base surgery.

Authors:  J F Kveton; C D Friedman; P D Costantino
Journal:  Am J Otol       Date:  1995-07

5.  Effects of magnesium on the formation of calcium-deficient hydroxyapatite from CaHPO4.2H2O and Ca4(PO4)2O.

Authors:  K S TenHuisen; P W Brown
Journal:  J Biomed Mater Res       Date:  1997-09-05

6.  Cements from nanocrystalline hydroxyapatite.

Authors:  J E Barralet; K J Lilley; L M Grover; D F Farrar; C Ansell; U Gbureck
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

7.  Hydroxyapatite cement: a new method for achieving watertight closure in transtemporal surgery.

Authors:  D B Kamerer; B E Hirsch; C H Snyderman; P Costantino; C D Friedman
Journal:  Am J Otol       Date:  1994-01

8.  Reconstruction of suboccipital craniectomy defects with hydroxyapatite cement: a preliminary report.

Authors:  J F Kveton; C D Friedman; J M Piepmeier; P D Costantino
Journal:  Laryngoscope       Date:  1995-02       Impact factor: 3.325

9.  Preparation of magnesium-substituted hydroxyapatite powders by the mechanochemical-hydrothermal method.

Authors:  Wojciech L Suchanek; Kullaiah Byrappa; Pavel Shuk; Richard E Riman; Victor F Janas; Kevor S TenHuisen
Journal:  Biomaterials       Date:  2004-08       Impact factor: 12.479

10.  Ionic modification of calcium phosphate cement viscosity. Part I: hypodermic injection and strength improvement of apatite cement.

Authors:  Uwe Gbureck; Jake E Barralet; Kerstin Spatz; Liam M Grover; Roger Thull
Journal:  Biomaterials       Date:  2004-05       Impact factor: 12.479

View more
  8 in total

1.  The role of ammonium citrate washing on the characteristics of mechanochemical-hydrothermal derived magnesium-containing apatites.

Authors:  Chun-Wei Chen; Wojciech L Suchanek; Pavel Shuk; Kullaiah Byrappa; Charles Oakes; Richard E Riman; Kelly Brown; Kevor S Tenhuisen; Victor F Janas
Journal:  J Mater Sci Mater Med       Date:  2007-02-06       Impact factor: 3.896

2.  Cement from nanocrystalline hydroxyapatite: effect of calcium phosphate ratio.

Authors:  K J Lilley; U Gbureck; A J Wright; D F Farrar; J E Barralet
Journal:  J Mater Sci Mater Med       Date:  2005-12       Impact factor: 3.896

3.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

4.  Effect of the calcium to phosphorus ratio on the setting properties of calcium phosphate bone cements.

Authors:  M D Vlad; S Gómez; M Barracó; J López; E Fernández
Journal:  J Mater Sci Mater Med       Date:  2012-05-26       Impact factor: 3.896

5.  Mg2+ substituted calcium phosphate nano particles synthesis for non viral gene delivery application.

Authors:  A Hanifi; M H Fathi; H Mir Mohammad Sadeghi; J Varshosaz
Journal:  J Mater Sci Mater Med       Date:  2010-05-13       Impact factor: 3.896

6.  Molecular mechanisms of crystallization impacting calcium phosphate cements.

Authors:  Jennifer L Giocondi; Bassem S El-Dasher; George H Nancollas; Christine A Orme
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2010-04-28       Impact factor: 4.226

7.  Injectability of brushite-forming Mg-substituted and Sr-substituted alpha-TCP bone cements.

Authors:  S Pina; P M C Torres; J M F Ferreira
Journal:  J Mater Sci Mater Med       Date:  2009-10-23       Impact factor: 3.896

8.  Cytocompatibility of the selected calcium phosphate based bone cements: comparative study in human cell culture.

Authors:  Radosław Olkowski; Piotr Kaszczewski; Joanna Czechowska; Dominika Siek; Dawid Pijocha; Aneta Zima; Anna Ślósarczyk; Małgorzata Lewandowska-Szumieł
Journal:  J Mater Sci Mater Med       Date:  2015-10-28       Impact factor: 3.896

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.